Toyota To Elevate Mountain Experience Of Vail Resorts' Guests As Mobility Partner

Mountain resort operator Vail Resorts (MTN) and Toyota (TYT.L,TM) have announced a multi-year partnership across the 33 mountain resorts in Vail Resorts' U.S. portfolio. As Vail Resorts' first-ever Mobility Partner, Toyota will provide fuel-efficient transportation, and best-in-class activities for guests. Also, Toyota will provide vehicles for Vail Resorts' mountain operations team members.

During the 2021/22 winter season, the companies will provide complimentary courtesy vehicles at 20 properties — a valet service that transports lodging guests around town and to nearby trails.

The Toyota fleet will include all-wheel drive vehicles with off-road capabilities, including RAV4 Hybrids, 4Runners, and Highlander Hybrids.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT